HIP
NVCR icon

HUB Investment Partners’s NovoCure NVCR Stock Holding History

HUB Investment Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Buy
16,634
+3,094
+23% +$38.6K ﹤0.01% 1010
2025
Q4 		$175K Buy
+13,540
New +$174K ﹤0.01% 864

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

HUB Investment Partners's NVCR Position: Q1 2026 in Review

HUB Investment Partners increased its NovoCure (NVCR) stake by 23% in Q1 2026, buying an estimated $38.6K and bringing the position to 16,634 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

HUB Investment Partners first reported a position in NVCR in Q4 2025 and has held it in 2 quarters since. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • HUB Investment Partners held 16,634 shares of NovoCure worth $181K as of Q1 2026.
  • HUB Investment Partners bought 3,094 NovoCure shares in Q1 2026, an estimated $38.6K.
  • NovoCure made up ﹤0.01% of HUB Investment Partners's portfolio in Q1 2026, its #1010 holding.
  • HUB Investment Partners first reported a position in NovoCure in Q4 2025 and has held it in 2 quarters since.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.